[FG] European Center for Pharmaceutical Medicine (ECPM)

Meier, Niklaus et al. (2025) ‘Systematic review of cost-effectiveness modelling studies for haemophilia’, Journal of Medical Economics, 28(1), pp. 89–104. Available at: https://doi.org/10.1080/13696998.2024.2444157.

El Saadany, T. et al. (2025) ‘A cost-effectiveness analysis of sotorasib as second-line treatment for patients with KRAS-G12C-mutated metastatic non-small cell lung cancer (mNSCLC) in Switzerland’, Swiss Medical Weekly, 155(1), p. 3777. Available at: https://doi.org/10.57187/s.3777.

El Saadany,Tämer et al. (2025) ‘A cost-effectiveness analysis of sotorasib as second-line treatment for patients with KRAS-G12C-mutated metastatic non-small cell lung cancer (mNSCLC) in Switzerland’, Swiss Medical Weekly, 155(1), p. 3777. Available at: https://doi.org/10.57187/s.3777.

Meier, N. et al. (2025) ‘Systematic review of cost-effectiveness modelling studies for haemophilia’, Journal of Medical Economics, 28(1), pp. 89–104. Available at: https://doi.org/10.1080/13696998.2024.2444157.

Schulthess-Lisibach, Angela Edith et al. (2025) ‘DepRescribing inapprOpriate Proton Pump InhibiTors (DROPIT): study protocol of a cluster-randomised controlled trial in Swiss primary care’, BMJ Open, 15(1), p. e094495. Available at: https://doi.org/10.1136/bmjopen-2024-094495.

Griessbach, Alexandra et al. (2024) ‘Resource use and costs of investigator-sponsored randomized clinical trials in Switzerland, Germany, and the United Kingdom: a metaresearch study’, Journal of Clinical Epidemiology, 176, p. 111536. Available at: https://doi.org/10.1016/j.jclinepi.2024.111536.

Jungo, Katharina Tabea et al. (2024) ‘Correction to: A mixed methods analysis of the medication review intervention centered around the use of the ‘Systematic Tool to Reduce Inappropriate Prescribing’ Assistant (STRIPA) in Swiss primary care practices (BMC Health Services Research, (2024), 24, 1, (350), 10.1186/s12913-024-10773-y)’, BMC Health Services Research, 24(1). Available at: https://doi.org/10.1186/s12913-024-10896-2.

Jungo, Katharina Tabea et al. (2024) ‘A mixed methods analysis of the medication review intervention centered around the use of the ‘Systematic Tool to Reduce Inappropriate Prescribing’ Assistant (STRIPA) in Swiss primary care practices’, BMC Health Services Research, 24(1). Available at: https://doi.org/10.1186/s12913-024-10773-y.

Griessbach, Alexandra et al. (2024) ‘Design and rationale for an empirical investigation of the resource use and costs of investigator-initiated randomized trials in Switzerland, the UK, and Germany’, Trials, 25(1). Available at: https://doi.org/10.1186/s13063-024-08505-y.

Wyss, C.A. et al. (2024) ‘Transcatheter aortic valve implantation with SAPIEN 3 versus surgical aortic valve replacement in patients with symptomatic severe aortic stenosis at low risk of surgical mortality: a cost-utility analysis for Switzerland’, Swiss Medical Weekly, 154(10), p. 3558. Available at: https://doi.org/10.57187/s.3558.

Falke, Charlotte et al. (2024) ‘The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy’, European Geriatric Medicine, 15(6), pp. 1713–1723. Available at: https://doi.org/10.1007/s41999-024-01036-4.

Saadany, Tämer El et al. (2024) ‘Bedside manufacturing as the next step in personalized medicine: medical progress and legal challenges’, Journal of Law and the Biosciences, 11(2). Available at: https://doi.org/10.1093/jlb/lsae012.

Stoffel, S.T. et al. (2024) ‘Herding-like behaviour in medical decision making: An experimental study investigating general practitioners’ prescription behaviour’, PLoS ONE, 19(7 July). Available at: https://doi.org/10.1371/journal.pone.0297019.

Griessbach, A. et al. (2024) ‘Design and rationale for an empirical investigation of the resource use and costs of investigator-initiated randomized trials in Switzerland, the United Kingdom, and Germany’. Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-3881507/v1.

Meier, Niklaus et al. (2024) ‘Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany’, PharmacoEconomics - Open, 8(3), pp. 373–387. Available at: https://doi.org/10.1007/s41669-024-00480-z.

Meier, Niklaus et al. (2024) ‘Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany’, PharmacoEconomics - Open, 8(3), pp. 373–387. Available at: https://doi.org/10.1007/s41669-024-00480-z.

Jungo, Katharina Tabea et al. (2024) ‘Cost-effectiveness of a medication review intervention for general practitioners and their multimorbid older patients with polypharmacy’, Socio-Economic Planning Sciences, 92. Available at: https://doi.org/10.1016/j.seps.2024.101837.

Mehra, T. et al. (2024) ‘Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer’, PLoS ONE, 19(4 April). Available at: https://doi.org/10.1371/journal.pone.0301271.

Janiaud, Perrine et al. (2024) ‘MultiSCRIPT-Cycle 1- A Pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in Multiple Sclerosis: a study protocol for a randomized clinical trial’, medRxiv [Preprint]. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2024.03.22.24304720.

Parisi, Ioanna et al. (2024) ‘Evaluation of the safety, efficacy and feasibility of ‘at-home’ capsule endoscopy’, Frontline Gastroenterology. 26.02.2024, p. Online ahead of print. Available at: https://doi.org/10.1136/flgastro-2023-102565.

Kappos, E.A. et al. (2024) ‘The LYMPH Trial - Comparing Microsurgical with Conservative Treatment of Chronic Breast Cancer Associated Lymphedema: Study Protocol of a Pragmatic Randomized International Multicentre Superiority Trial’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2024.02.13.24302744.

Stoffel, Sandro T et al. (2024) ‘Testing Behavioral Messages to Increase Recruitment to Health Research When Embedded Within Social Media Campaigns on Twitter: Web-Based Experimental Study’, JMIR Formative Research, 8. Available at: https://doi.org/10.2196/48538.

Stoffel, Sandro Tiziano, Chaki, Biswajit and Vlaev, Ivo (2024) ‘Testing a decoy donation incentive to improve online survey participation: Evidence from a field experiment’, PLoS ONE, 19(2 February), p. e0299711. Available at: https://doi.org/10.1371/journal.pone.0299711.

Mai D, Szucs T (2024) ‘Gesundheitsversorgung im Strafvollzug Recht und Ethik in der Schweiz.’, Jusletter [Preprint].

Mollet, Annette, Laskowski, Nastazja and Szucs, Thomas (2024) ‘Postgraduate education and training in drug development sciences: 30 years of the european center of pharmaceutical medicine’, Frontiers in Pharmacology, 15. Available at: https://doi.org/10.3389/fphar.2024.1389349.

Schaffner E, Szucs TD (2024) ‘Gesundheitsversorgung im Strafvollzug Recht und Ethik in der Schweiz. Die Anwendung des Auskunftsrechts, des Rechts auf Berichtigung und des Rechts auf Löschung in Schweizer Spitälern.’, Life Science Recht [Preprint].

Schur, Nadine et al. (2024) ‘Cost-effectiveness of pembrolizumab as an adjuvant treatment of renal cell carcinoma post-nephrectomy in Switzerland’, Journal of Medical Economics, 27(1), pp. 1389–1397. Available at: https://doi.org/10.1080/13696998.2024.2417523.

Schur, Nadine et al. (2024) Helsana-Arzneimittelreport 2024. . Translated by Helsana. ECPM, Universität Basel. Available at: https://reports.helsana.ch/arzneimittel2024/.

Barbier, Michaela Carla et al. (2023) ‘Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland’, PharmacoEconomics. 12.08.2023, 41(12), pp. 1641–1655. Available at: https://doi.org/10.1007/s40273-023-01305-3.

Serra-Burriel, M. et al. (2023) ‘Real-World Cost-Effectiveness of Pulmonary Vein Isolation for Atrial Fibrillation: A Target Trial Approach’, Value in Health, 26(12), pp. 1721–1729. Available at: https://doi.org/10.1016/j.jval.2023.08.008.

Stoffel, S.T. et al. (2023) ‘Testing the decoy effect to improve online survey participation: Evidence from a field experiment’, Journal of Behavioral and Experimental Economics. 16.09.2023, 107. Available at: https://doi.org/10.1016/j.socec.2023.102103.

Meinlschmidt, Gunther et al. (2023) ‘Prevention of psychosocial distress consequences in somatic hospital inpatients via a stepped and collaborative care model: protocol of SomPsyNet, a stepped wedge cluster randomised trial’, BMJ Open, 13(11). Available at: https://doi.org/10.1136/bmjopen-2023-076814.

Foster-Witassek, Fabienne et al. (2023) ‘Longitudinal Changes in Health-Related Quality of Life in Patients With Atrial Fibrillation’, Journal of the American Heart Association, 12(21). Available at: https://doi.org/10.1161/JAHA.123.031872.

Gerold, Jana et al. (2023) Schlussbericht Evaluation StoppSturz. . Translated by Gesundheitsförderung Schweiz. Schlussbericht. ECPM, University of Basel. Available at: https://gesundheitsfoerderung.ch/sites/default/files/2024-01/20231024_PGV01.077_Stoppsturz_EvalSchlussbericht_UniBas.pdf.

Pinsent A et al. (2023) ‘Determining the Relationship Between Seizure-Free Days and Other Predictors of Quality of Life in Patients with Dravet Syndrome and Their Carers from FFA Registration Studies’, Neurology and Therapy, 12(5), pp. 1593–1606. Available at: https://doi.org/10.1007/s40120-023-00510-8.

Trottmann, Maria et al. (2023) ‘Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data’, Swiss Medical Weekly, 153(9), p. s3441. Available at: https://doi.org/10.57187/s.3441.

Aebersold, Helena et al. (2023) ‘Estimating the cost impact of atrial fibrillation using a prospective cohort study and population-based controls’, BMJ Open, 13(9). Available at: https://doi.org/10.1136/bmjopen-2023-072080.

Cook, B. et al. (2023) ‘Consumer Interaction with Sustainability Labelling on Food Products: A Narrative Literature Review’, Nutrients, 15(17), p. 3837. Available at: https://doi.org/10.3390/nu15173837.

Gorini, G. et al. (2023) ‘Testing behavioral economics messages to increase non-responders” participation in organized colorectal cancer-screening programs: A randomized controlled trial’, Preventive Medicine, 174. Available at: https://doi.org/10.1016/j.ypmed.2023.107615.

Roos J et al. (2023) ‘Time requirements for perioperative glucose management using fully closed-loop versus standard insulin therapy: A proof-of-concept time–motion study’, Diabetic Medicine, 40(9), p. e15116. Available at: https://doi.org/10.1111/dme.15116.

Sibille FX et al. (2023) ‘Benzodiazepine Receptor Agonists Use and Cessation Among Multimorbid Older Adults with Polypharmacy: Secondary Analysis from the OPERAM Trial’, Drugs and Aging, 40(6), pp. 551–561. Available at: https://doi.org/10.1007/s40266-023-01029-1.

Stoffel ST, Schwenkglenks M and Mutschler T (2023) ‘General Practitioners’ Awareness and Perception of Current Pneumococcal Vaccination for Adult Patients with Known Risk Factors in Switzerland: Evidence from a Survey’, Vaccines, 11(6). Available at: https://doi.org/10.3390/vaccines11061101.

Aebersold, Helena et al. (2023) ‘Patient clusters and cost trajectories in the Swiss Atrial Fibrillation cohort’, Heart, 109(10), pp. 763–770. Available at: https://doi.org/10.1136/heartjnl-2022-321520.

Herber, Elena et al. (2023) ‘Physical activity and brain health in patients with atrial fibrillation’, European Journal of Neurology, 30(3), pp. 567–577. Available at: https://doi.org/10.1111/ene.15660.

Aebi, N. J. et al. (2023) ‘Facilitators and barriers of routine psychosocial distress assessment within a stepped and collaborative care model in a Swiss hospital setting’, PLoS One, 18(6), p. e0285395. Available at: https://doi.org/10.1371/journal.pone.0285395.

Finazzi, Tobias et al. (2023) ‘Patient Reported Outcome Measures (PROMs) in a multidisciplinary lung cancer centre: a value-based healthcare pilot project’, SOCH. Schweiz (SOCH), 1 January. Available at: https://www.researchgate.net/publication/378675035_Patient_Reported_Outcome_Measures_PROMs_in_a_multidisciplinary_lung_cancer_centre_a_value-based_healthcare_pilot_project.

Girardin FR et al. (2023) ‘Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment’, 14. Available at: https://doi.org/10.3389/fphar.2023.1210002.

Jungo KT et al. (2023) ‘Optimising prescribing in older adults with multimorbidity and polypharmacy in primary care (OPTICA): cluster randomised clinical trial’, BMJ, 381, p. e074054. Available at: https://doi.org/10.1136/bmj-2022-074054.

Salari P et al. (2023) ‘Healthcare Costs and Health-Related Quality of Life in Older Multimorbid Patients After Hospitalization’, Health Services Insights, 16, p. 11786329231153278. Available at: https://doi.org/10.1177/11786329231153278.

Schur, Nadine et al. (2023) Helsana-Arzneimittelreport 2023. . Translated by Helsana. ECPM, University of Basel. Available at: https://reports.helsana.ch/wp-content/uploads/2023/11/Helsana_AMR2023_online.pdf.

Stoffel S.T. et al. (2023) ‘Testing temporal frames of colorectal cancer risks: evidence from randomized online experiments’, Psychology, Health and Medicine, 28(2), pp. 375–389. Available at: https://doi.org/10.1080/13548506.2022.2061716.

Meyre, Pascal B. et al. (2022) ‘Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing’, European Heart Journal, 43(47), pp. 4899–4908. Available at: https://doi.org/10.1093/eurheartj/ehac587.

Blum, Steffen et al. (2022) ‘Long-term risk of adverse outcomes according to atrial fibrillation type’, Scientific Reports, 12(1). Available at: https://doi.org/10.1038/s41598-022-05688-9.

Menges, Dominik et al. (2022) ‘Treatments for Metastatic Hormone-sensitive Prostate Cancer: Systematic Review, Network Meta-analysis, and Benefit-harm assessment’, European urology oncology, 5(6), pp. 605–616. Available at: https://doi.org/10.1016/j.euo.2022.04.007.

Menges D et al. (2022) ‘Treatments for Metastatic Hormone-sensitive Prostate Cancer: Systematic Review, Network Meta-analysis, and Benefit-harm assessment’, European urology oncology, 5(6), pp. 605–616. Available at: https://doi.org/10.1016/j.euo.2022.04.007.

Stoffel, Sandro T et al. (2022) ‘Effect of communicating community immunity on COVID-19 vaccine-hesitant people from ethnically diverse backgrounds: an experimental vignette study in the UK’, BMJ Open, 12(11), p. e065804. Available at: https://doi.org/10.1136/bmjopen-2022-065804.

Stoffel ST et al. (2022) ‘Effect of communicating community immunity on COVID-19 vaccine-hesitant people from ethnically diverse backgrounds: an experimental vignette study in the UK’, BMJ Open, 12(11), p. e065804. Available at: https://doi.org/10.1136/bmjopen-2022-065804.

Barbier MC et al. (2022) ‘Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancer’, PLoS ONE, 17(11 November), p. e0277282. Available at: https://doi.org/10.1371/journal.pone.0277282.

Barbier, Michaela C et al. (2022) ‘Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancer’, PLoS ONE, 17(11 November), p. e0277282. Available at: https://doi.org/10.1371/journal.pone.0277282.

Jungo, K.T. et al. (2022) ‘Optimizing Prescribing in Older Adults with Multimorbidity and Polypharmacy in Primary Care: A Cluster Randomized Clinical Trial (OPTICA Trial)’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2022.10.31.22281164.

Stoffel S.T. et al. (2022) ‘Pneumococcal vaccination among adult risk patient with axial spondyloarthritis in Switzerland: Data from the survey of the ankylosing spondylitis association of Switzerland (SVMB)’, Vaccine, 40(43), pp. 6206–6210. Available at: https://doi.org/10.1016/j.vaccine.2022.09.056.

Pinsent, A. et al. (2022) Determining the Relationship between Seizure-Free Days and Other Predictors of Quality of Life in Patients with Dravet Syndrome and Their Carers. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2022.10.07.22280500.

Galactionova, Katya et al. (2022) ‘Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial’, Frontiers in Oncology, 12, p. 886831. Available at: https://doi.org/10.3389/fonc.2022.886831.

Galactionova K et al. (2022) ‘Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial’, Frontiers in Oncology, 12, p. 886831. Available at: https://doi.org/10.3389/fonc.2022.886831.

Girod M et al. (2022) ‘Association of pulmonary vein isolation and major cardiovascular events in patients with atrial fibrillation’, Clinical Research in Cardiology, 111(9), pp. 1048–1056. Available at: https://doi.org/10.1007/s00392-022-02015-0.

Galactionova, Katya et al. (2022) ‘Correction to: Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease (PharmacoEconomics, (2022), 40, 8, (791-806), 10.1007/s40273-022-01152-8)’, PharmacoEconomics, 40(8), p. 835. Available at: https://doi.org/10.1007/s40273-022-01171-5.

Galactionova K et al. (2022) ‘Correction to: Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease (PharmacoEconomics, (2022), 40, 8, (791-806), 10.1007/s40273-022-01152-8)’, 40(8). Available at: https://doi.org/10.1007/s40273-022-01171-5.

Galactionova K et al. (2022) ‘Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease’, PharmacoEconomics, 40(8), pp. 791–806. Available at: https://doi.org/10.1007/s40273-022-01152-8.

Stoffel, Sandro T. et al. (2022) ‘Testing the Effectiveness of an Animated Decision Aid to Improve Recruitment of Control Participants in a Case-Control Study: Web-Based Experiment’, Journal of Medical Internet Research, 24(8), p. ARTN e40015. Available at: https://doi.org/10.2196/40015.

Stoffel S.T. et al. (2022) ‘Testing the Effectiveness of an Animated Decision Aid to Improve Recruitment of Control Participants in a Case-Control Study: Web-Based Experiment’, Journal of Medical Internet Research, 24(8). Available at: https://doi.org/10.2196/40015.

Linley, W. et al. (2022) Comparative effectiveness of fenfluramine versus cannabidiol in their licensed indications for the treatment of seizures in Dravet Syndrome: a systematic review and network meta-analysis. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2022.07.01.22277155.

Sendi P and Schwenkglenks M (2022) ‘Risk-Adjusted Performance Measures: A Comment on Elbasha’, 40(7). Available at: https://doi.org/10.1007/s40273-022-01153-7.

Helena, A. et al. (2022) Patient Clusters and Cost Trajectories in Atrial Fibrillation: Evidence from the Swiss Atrial Fibrillation Cohort. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2022.06.07.22275906.

Kühne, Michael et al. (2022) ‘Silent brain infarcts impact on cognitive function in atrial fibrillation’, European Heart Journal, 43(22), pp. 2127–2135. Available at: https://doi.org/10.1093/eurheartj/ehac020.

Mark, Michael et al. (2022) ‘RE: Real-World Use of Bone Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer’, Journal of the National Cancer Institute, 114(4), pp. 635–636. Available at: https://doi.org/10.1093/jnci/djab216.

Mark M. et al. (2022) ‘RE: Real-World Use of Bone Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer’, Journal of the National Cancer Institute, 114(4), pp. 635–636. Available at: https://doi.org/10.1093/jnci/djab216.

Speich, Benjamin et al. (2022) ‘Nonregistration, discontinuation, and nonpublication of randomized trials: A repeated metaresearch analysis’, PLoS Medicine, 19(4), p. e1003980. Available at: https://doi.org/10.1371/journal.pmed.1003980.

Taylor L.C. et al. (2022) ‘Effectiveness of behavioural economics-based interventions to improve colorectal cancer screening participation: A rapid systematic review of randomised controlled trials’, Preventive Medicine Reports, 26. Available at: https://doi.org/10.1016/j.pmedr.2022.101747.

Bretagne L et al. (2022) ‘[Polypharmacy and inappropriate medications in multimorbid elderly patients - What OPERAM taught us and will teach us].’, Revue medicale suisse, 18(772), pp. 427–432. Available at: https://doi.org/10.53738/revmed.2022.18.772.427.

Tomonaga Y et al. (2022) ‘Early mobilisation and rehabilitation in Swiss intensive care units: A cross-sectional survey’, Swiss Medical Weekly, 152(3), p. w30125. Available at: https://doi.org/10.4414/smw.2022.w30125.

Aebi, Nicola J. et al. (2022) ‘Association of different restriction levels with COVID-19-related distress and mental health in somatic inpatients: a secondary analysis of swiss general hospital data’, Frontiers in Psychiatry. 03.05.2022, 13. Available at: https://doi.org/10.3389/fpsyt.2022.872116.

Bandiera, Carole et al. (2022) ‘Swiss Priority Setting on Implementing Medication Adherence Interventions as Part of the European ENABLE COST Action’, International Journal of Public Health, 67, p. 1605204. Available at: https://doi.org/10.3389/ijph.2022.1605204.

Bhadhuri, Arjun et al. (2022) ‘Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland’, BMC Health Services Research, 22(1), p. 837. Available at: https://doi.org/10.1186/s12913-022-08211-y.

Cavalli, L. et al. (2022) ‘Number of comorbidities and their impact on perioperative outcome and costs - a single centre cohort study’, Swiss Med Wkly, 152, p. w30135. Available at: https://doi.org/10.4414/smw.2022.w30135.

Gruebner O et al. (2022) ‘Small Area Variation of Adherence to Clinical Recommendations: An Example from Switzerland’, Health Services Research and Managerial Epidemiology, 9, p. 23333928221097741. Available at: https://doi.org/10.1177/23333928221097741.

Gryaznov, D. et al. (2022) ‘Reporting quality of clinical trial protocols: a repeated cross-sectional study about the Adherence to SPIrit recommendations in Switzerland, CAnada and GErmany (ASPIRE-SCAGE)’, BMJ Open, 12(5), p. e053417. Available at: https://doi.org/10.1136/bmjopen-2021-053417.

Salari, Paola et al. (2022) ‘Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study’, PLoS One, 17(4), p. e0265507. Available at: https://doi.org/10.1371/journal.pone.0265507.

Siqeca, Flaka et al. (2022) ‘Factors associated with health-related quality of life among home-dwelling older adults aged 75 or older in Switzerland: a cross-sectional study’, Health and Quality of Life Outcomes, 20(1), p. 166. Available at: https://doi.org/10.1186/s12955-022-02080-z.

Speich, B. et al. (2022) ‘Nonregistration, discontinuation, and nonpublication of randomized trials: a repeated metaresearch analysis’, PLoS Med, 19(4), p. e1003980. Available at: https://doi.org/10.1371/journal.pmed.1003980.

Stoffel, Sandro T. et al. (2022) ‘Evaluation of the Call for a Kit intervention to increase bowel cancer screening uptake in Lancashire, England’, Journal of Medical Screening, 29(3), pp. 166–171. Available at: https://doi.org/10.1177/09691413221089184.

Stoffel ST et al. (2022) ‘Testing Enhanced Active Choice to Optimize Acceptance and Participation in a Population-Based Colorectal Cancer Screening Program in Malta’, Behavioral Medicine, 48(3), pp. 141–146. Available at: https://doi.org/10.1080/08964289.2020.1828254.

Yip, Olivia et al. (2022) ‘Health and social care of home-dwelling frail older adults in Switzerland: a mixed methods study’, BMC Geriatrics, 22(1), p. 857. Available at: https://doi.org/10.1186/s12877-022-03552-z.

Yip, Olivia et al. (2022) ‘Protocol for a mixed methods feasibility and implementation study of a community-based integrated care model for home-dwelling older adults: The INSPIRE project’, PLoS ONE, 17(12), p. e0278767. Available at: https://doi.org/10.1371/journal.pone.0278767.

Zgraggen, Armin et al. (2022) ‘Colorectal cancer surveillance by colonoscopy in a prospective, population-based long-term Swiss screening study - outcomes, adherence, and costs’, Zeitschrift für Gastroenterologie, 60(05), pp. 761–778. Available at: https://doi.org/10.1055/a-1796-2471.

Marbet, U. A., Stoffel, S. T. and Brunner-Schaub, N. (2022) ‘Dickdarmkrebs-Screening in der Schweiz: Sind unsere Patienten genügend motiviert? Eine narrative Review darüber, was unsere Teilnahme am Dickdarmkrebsscreening bestimmt’, Schweizer Gastroenterologie. 5.7.2022, 3, p. 11. Available at: https://doi.org/10.1007/s43472-022-00076-0.

Sibylle Twerenbold et al. (2022) ‘Helsana Arzneimittelreport 2022’.

Stoffel S et al. (2021) ‘Testing messages from behavioral economics to improve participation in a population-based colorectal cancer screening program in Cyprus: Results from two randomized controlled trials’, Preventive Medicine Reports, 24, p. 101499. Available at: https://doi.org/10.1016/j.pmedr.2021.101499.

Kappos EA et al. (2021) ‘Prepectoral versus subpectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy (OPBC-02/ PREPEC): A pragmatic, multicentre, randomised, superiority trial’, BMJ Open, 11(9), p. e045239. Available at: https://doi.org/10.1136/bmjopen-2020-045239.

Reinau D et al. (2021) ‘Utilisation patterns and costs of lipid-lowering drugs in Switzerland 2013-2019’, Swiss Medical Weekly, 151(35), p. w30018. Available at: https://doi.org/10.4414/SMW.2021.w30018.

Blum MR et al. (2021) ‘Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): Cluster randomised controlled trial’, The BMJ, 374, p. n1585. Available at: https://doi.org/10.1136/bmj.n1585.